Mary L. Smith

Insider Reports History

Location
South Plainfield, NJ
Signature
/s/ Avraham S. Adler, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mary L. Smith:

Company Role Class Num Shares Value Price $ Report Date Ownership
PTC THERAPEUTICS, INC. Director Common Stock 21,813 $1,656,915 $75.96 02 Jan 2026 Direct
PTC THERAPEUTICS, INC. Director Stock Option (Right to Buy) 3,475 $238,040 $27.05 02 Jan 2026 Direct

Insider Reports Filed by Mary L. Smith

Symbol Company Period Transactions Value $ Form Type Role Filing Time
PTCT PTC THERAPEUTICS, INC. 02 Jan 2026 2 $0 4 Director 06 Jan 2026, 17:23
PTCT PTC THERAPEUTICS, INC. 03 Jan 2025 2 $0 4 Director 07 Jan 2025, 17:20
PTCT PTC THERAPEUTICS, INC. 15 Feb 2024 2 $0 4 Director 16 Feb 2024, 16:10
PTCT PTC THERAPEUTICS, INC. 05 Jan 2023 2 $0 4 Director 09 Jan 2023, 15:09
PTCT PTC THERAPEUTICS, INC. 07 Jan 2022 2 $0 4 Director 11 Jan 2022, 15:15
PTCT PTC THERAPEUTICS, INC. 11 Jun 2021 4 $0 4 Director 15 Jun 2021, 17:24
PTCT PTC THERAPEUTICS, INC. 08 Jun 2021 0 $0 3 Director 15 Jun 2021, 17:15